These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 8638328

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Reinfection with Schistosoma haematobium and mansoni despite repeated praziquantel office treatment in Niger, Mali].
    Dabo A, Doucoure B, Koita O, Diallo M, Kouriba B, Klinkert MQ, Doumbia S, Doumbo O.
    Med Trop (Mars); 2000; 60(4):351-5. PubMed ID: 11436587
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Combined Schistosoma mansoni and Schistosoma haematobium infection.
    Mahmood A, Yasir M.
    J Coll Physicians Surg Pak; 2005 Jul; 15(7):443-4. PubMed ID: 16197880
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The impact of single versus mixed Schistosoma haematobium and S. mansoni infections on morbidity profiles amongst school-children in Taveta, Kenya.
    Gouvras AN, Kariuki C, Koukounari A, Norton AJ, Lange CN, Ireri E, Fenwick A, Mkoji GM, Webster JP.
    Acta Trop; 2013 Nov; 128(2):309-17. PubMed ID: 23313322
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Seasonality as a determinant of the efficacy of praziquantel in population-based chemotherapy: lessons from the practice.
    Abu-Elyazeed RR, Mansour NS, Youssef FG, Boghdadi AM, el Khoby TA, Hassanein YA, el Gamal RR.
    J Egypt Soc Parasitol; 1998 Apr; 28(1):1-7. PubMed ID: 9617037
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of praziquantel treatment of schistosomiasis in a non-endemic country: a follow-up of parasitological, clinical and immunological parameters.
    Giboda M, Loudová J, Shonová O, Boucková E, Horácek J, Numrich P, Ruppel A, Vítovec J, Lukes S, Noll P.
    J Hyg Epidemiol Microbiol Immunol; 1992 Apr; 36(4):346-55. PubMed ID: 1300350
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Increase of intestinal schistosomiasis after praziquantel treatment in a Schistosoma haematobium and Schistosoma mansoni mixed focus.
    Ernould JC, Ba K, Sellin B.
    Acta Trop; 1999 Jul 30; 73(2):143-52. PubMed ID: 10465054
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic and operational profiles of metrifonate and praziquantel in Schistosoma haematobium infection.
    Feldmeier H, Chitsulo L.
    Arzneimittelforschung; 1999 Jul 30; 49(7):557-65. PubMed ID: 10442201
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of case management in the integrated schistosomiasis-control programme in Mali.
    Landouré A, van der Werf MJ, Traoré M, de Vlas SJ.
    Ann Trop Med Parasitol; 2003 Oct 30; 97(7):723-36. PubMed ID: 14613631
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Schistosomiasis: a review of cases in Wellington 1993-4.
    Nixon A, Nacey J, Russell G, Robinson R.
    N Z Med J; 1996 Jan 26; 109(1014):7-9. PubMed ID: 8628537
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.